Bill
Bill > HR7679
US HR7679
US HR7679To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.
summary
Introduced
05/06/2022
05/06/2022
In Committee
05/06/2022
05/06/2022
Crossed Over
Passed
Dead
01/03/2023
01/03/2023
Introduced Session
117th Congress
Bill Summary
A BILL To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.
AI Summary
This bill seeks to amend the Federal Food, Drug, and Cosmetic Act to extend the authority to grant certain exemptions. Specifically, it would reauthorize the Humanitarian Device Exemption (HDE) profit incentive by extending the sunset date from 2022 to 2027, and it would reauthorize the Pediatric Device Consortia Program by extending the funding authorization from fiscal years 2018-2022 to fiscal years 2023-2027. The HDE program allows for the marketing of medical devices intended to treat or diagnose rare diseases or conditions, and the Pediatric Device Consortia Program provides grants to facilitate the development of medical devices for children.
Committee Categories
Business and Industry
Sponsors (2)
Last Action
Referred to the House Committee on Energy and Commerce. (on 05/06/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/117th-congress/house-bill/7679/all-info |
| BillText | https://www.congress.gov/117/bills/hr7679/BILLS-117hr7679ih.pdf |
| Bill | https://www.congress.gov/117/bills/hr7679/BILLS-117hr7679ih.pdf.pdf |
Loading...